德国肺炎球菌结合疫苗接种程序变更前后接种率与依从性分析
基于德国理赔数据库的回顾性分析,比较2013年(3+1程序)与2016年(2+1程序)出生足月儿的肺炎球菌结合疫苗接种率与依从性。2016年队列24月龄时至少接种一剂的比例为90.9%,加强剂接种率为75.6%,但仅46.3%按时接种;未接种比例与2013年相近。
要点
- 程序改为2+1后,PCV加强剂接种率略有上升,但近四分之一婴儿未接种加强剂。
- 按时接种加强剂的比例仍不足一半,2016年队列为46.3%。
- 未接种婴儿比例在两个队列间保持稳定,未见明显下降。
核心结论
- 2+1程序实施后PCV加强剂接种率略有提高,但仍有近四分之一2016年出生婴儿未接种加强剂,且接种延迟常见、未接种率未变。
研究设计与样本
- 回顾性理赔数据分析,使用InGef研究数据库,纳入2013年或2016年出生的所有足月婴儿,随访24个月。
- 以推荐程序一致的六价联合疫苗(HEXA)作为参照进行分析。
主要发现
- 随访24个月后,2016年队列90.9%、2013年队列91.2%的婴儿至少接种一剂PCV。
- 2013年队列67.7%按3+1程序接种加强剂;2016年队列75.6%接种加强剂,其中71.7%按2+1程序、3.9%按3+1程序。
- 接种加强剂者中,2016年仅46.3%、2013年仅45.1%按时接种。
- HEXA接种率从2013年的88.9%升至2016年的91.6%,全程完成率从69.1%升至72.9%;按时加强接种比例从47.8%升至50.0%。
关键数值与推荐
- 2015年8月德国常设疫苗接种委员会(STIKO)将足月婴儿PCV程序从3+1改为2+1。
- 2013年出生队列为最后完全按3+1推荐接种的队列,2016年出生队列为最初完全按2+1推荐接种的队列。
临床怎么用
- 程序简化后仍需关注加强剂接种的及时性与覆盖率,尤其针对未接种和延迟接种的婴儿。
- 可利用理赔数据持续监测接种程序变更后的真实世界依从性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In August 2015, the German Standing Committee on Vaccination (STIKO) changed the pneumococcal conjugate vaccination (PCV) schedule for mature infants from a 3+1 scheme to a 2+1 scheme. It was expected that a reduction of doses would be associated with a higher acceptance of the vaccination. Aim of this study was to assess vaccination rates and adherence for PCV after the change of recommendation based on real-world data. METHODS: A retrospective claims data analysis using the InGef Research Database was conducted. The study population consisted of all mature infants born in 2013 (last birth cohort completely under 3+1 recommendation) or 2016 (first birth cohort completely under 2+1 recommendation) with an individual follow-up of 24 months. Hexavalent combination vaccination (HEXA) with a consistent 3+1 recommendation was analyzed as reference. RESULTS: After follow-up of 24 months, 90.9% (91.2%) of the 2016 (2013) cohort received at least one dose of PCV. At the same age, 67.7% of the 2013 cohort received a booster dose according to the 3+1 schedule and 75.6% of the 2016 cohort received a booster dose presumably either according to the 2+1 (71.7%) or 3+1 (3.9%) schedule. Of those receiving the booster dose, only 46.3% (2016) and 45.1% (2013) received the booster dose on time as recommended. The HEXA vaccination rate increased from 88.9% (2013) to 91.6% (2016) with a full series completion in 69.1% (2013) vs 72.9% (2016). The proportion of infants receiving the booster vaccination on time rose to 50.0% in 2016 (47.8% in 2013). CONCLUSIONS: Although the rate for the PCV booster dose slightly increased, nearly a quarter of the infants born in 2016 did not receive a booster dose at all. Furthermore, vaccinations were still frequently delayed, and the rate of unvaccinated infants remained constant.
引用
- Laurenz M, von Eiff C, Borchert K, et al. Vaccination rates and adherence in pneumococcal conjugate vaccination in mature born infants before and after vaccination schedule change - A claims database analysis. Vaccine. 2021. PMID: 33962835. doi:10.1016/j.vaccine.2021.04.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。